Results 1 to 10 of about 1,528,999 (362)

Lung Cancer and Interstitial Lung Diseases. [PDF]

Cancers (Basel)
Lung cancer continues to be one of the leading causes of cancer-related death worldwide. There is evidence of a complex interplay between lung cancer and interstitial lung disease (ILD), affecting disease progression, management strategies, and patient outcomes. Both conditions develop as the result of common risk factors such as smoking, environmental
Drakopanagiotakis F, Krauss E, Michailidou I, Drosos V, Anevlavis S, Günther A, Steiropoulos P.   +6 more
europepmc   +3 more sources

Calprotectin in Lung Diseases [PDF]

International Journal of Molecular Sciences, 2021
Calprotectin (CLP) is a heterodimer formed by two S-100 calcium-binding cytosolic proteins, S100A8 and S100A9. It is a multifunctional protein expressed mainly by neutrophils and released extracellularly by activated or damaged cells mediating a broad range of physiological and pathological responses.
Ourania S. Kotsiou, Dimitrios Papagiannis, Rodanthi Papadopoulou, Konstantinos I. Gourgoulianis   +3 more
openaire   +4 more sources

Chronic hypersensitivity pneumonitis is associated with an increased risk of venous thromboembolism: a retrospective cohort study

BMC Pulmonary Medicine, 2021
Background Idiopathic pulmonary fibrosis (IPF) and chronic hypersensitivity pneumonitis share commonalities in pathogenesis shifting haemostasis balance towards the procoagulant and antifibrinolytic activity.
Małgorzata Sobiecka, Monika Szturmowicz, Katarzyna Lewandowska, Agata Kowalik, Ewa Łyżwa, Katarzyna Zimna, Inga Barańska, Lilia Jakubowska, Jan Kuś, Renata Langfort, Witold Tomkowski   +10 more
doaj   +1 more source

Fibrinolytic Therapy in Purulent Pericarditis

Reviews in Cardiovascular Medicine, 2023
Purulent pericarditis (PP) is rare disease, and if left untreated, it is associated with very high mortality, nearly 100%. A considerable clinical problem due to PP is a very high probability of developing constrictive pericarditis (CP).
Małgorzata Dybowska, Monika Szturmowicz, Katarzyna Lewandowska, Małgorzata Sobiecka, Witold Tomkowski   +4 more
doaj   +1 more source

Sudden Vision Loss Due to Optic Neuritis—An Uncommon Presentation of Neurosarcoidosis

Diagnostics, 2023
Sarcoidosis is a systemic, granulomatous disease of unknown etiology, most often manifested by mediastinal and hilar lymph node enlargement and parenchymal nodules in the lungs. However, it may involve any other organ. Neuro-sarcoidosis, a condition that
Katarzyna Zimna, Monika Szturmowicz, Małgorzata Sobiecka, Katarzyna Błasińska, Małgorzata Bartosiewicz, Witold Z. Tomkowski   +5 more
doaj   +1 more source

Acute Eosinophilic Pneumonia Complicated with Venous Thromboembolic Disease—Diagnostic and Therapeutic Considerations

Diagnostics, 2022
Acute Eosinophilic Pneumonia (AEP) is a rare idiopathic disease caused by an accumulation of eosinophils in the pulmonary alveoli and interstitial tissue of the lungs. The onset of symptoms is acute; some patients develop respiratory failure.
Ewa Jankowska, Iwona Bartoszuk, Katarzyna Lewandowska, Małgorzata Dybowska, Lucyna Opoka, Witold Tomkowski, Monika Szturmowicz   +6 more
doaj   +1 more source

An Unfavorable Outcome of M. chimaera Infection in Patient with Silicosis

Diagnostics, 2022
Mycobacterium chimaera is a slow-growing, nontuberculous mycobacterium (NTM) belonging to the Mycobacterium avium complex (MAC). It was identified as a unique species in 2004.
Ewa Łyżwa, Izabela Siemion-Szcześniak, Małgorzata Sobiecka, Katarzyna Lewandowska, Katarzyna Zimna, Małgorzata Bartosiewicz, Lilia Jakubowska, Ewa Augustynowicz-Kopeć, Witold Tomkowski   +8 more
doaj   +1 more source

Bronchoalveolar Lavage Cell Count and Lymphocytosis Are the Important Discriminators between Fibrotic Hypersensitivity Pneumonitis and Idiopathic Pulmonary Fibrosis

Diagnostics, 2023
Background: Fibrotic hypersensitivity pneumonitis (fHP) shares many features with other fibrotic interstitial lung diseases (ILD), and as a result it can be misdiagnosed as idiopathic pulmonary fibrosis (IPF).
Małgorzata Sobiecka, Monika Szturmowicz, Katarzyna B. Lewandowska, Inga Barańska, Katarzyna Zimna, Ewa Łyżwa, Małgorzata Dybowska, Renata Langfort, Piotr Radwan-Röhrenschef, Adriana Roży, Witold Z. Tomkowski   +10 more
doaj   +1 more source

New 6-Minute-Walking Test Parameter—Distance/Desaturation Index (DDI) Correctly Diagnoses Short-Term Response to Immunomodulatory Therapy in Hypersensitivity Pneumonitis

Diagnostics, 2023
The six-minute-walking test (6MWT) is an easy-to-perform, cheap and valuable tool to assess the physical performance of patients. It has been used as one of the endpoints in many clinical trials investigating treatment efficacy in pulmonary arterial ...
Katarzyna B. Lewandowska, Małgorzata Sobiecka, Piotr W. Boros, Małgorzata Dybowska, Inga Barańska, Małgorzata E. Jędrych, Agata Gładzka, Witold Z. Tomkowski, Monika Szturmowicz   +8 more
doaj   +1 more source

Prolonged SARS-CoV-2 Infection and Organizing Pneumonia in a Patient with Follicular Lymphoma, Treated with Obinutuzumab—Challenging Recognition and Treatment

Viruses, 2023
A Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing coronavirus disease 2019 (COVID-19) led to a pandemic outbreak in 2019. COVID-19’s course and its treatment in immunocompromised patients are uncertain.
E. Łyżwa, M. Sobiecka, K. Lewandowska, I. Siemion-Szcześniak, I. Barańska, M. Klatt, R. Langfort, M. Szturmowicz, W. Tomkowski   +8 more
doaj   +1 more source